The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1245 Weight Loss articles
Urban elites are currently the main drivers behind the increasing popularity of GLP-1 weight loss medications. Changes in distribution strategies and price adjustments could potentially transform this trend. These factors could democratize access to these treatments.
As the holiday season approaches, many individuals express concerns regarding potential weight gain. Prestige Men's Health in Holladay is offering medically supervised weight-loss programs using GLP-1 treatments like semaglutide, providing screening, labs, and continuous monitoring. This comes as more Utah residents seek medical guidance for weight management during this time.
A clinical trial is underway to test a new weight-loss treatment for cats using a drug class similar to Ozempic. The study, called MEOW-1, involves an implant administering medication to help overweight cats shed pounds.
An ITV presenter, known for her financial expertise on Lorraine, has publicly discussed her weight loss journey. She attributes her four-stone weight loss to the use of Mounjaro, resulting in a significant change in her dress size.
The rise of GLP-1 drugs has sparked interest across various industries, including beauty. While some claims may seem like clickbait, the need for skincare innovation to address skin changes related to these medications is real. Experts and research suggest GLP-1 skincare is a legitimate response to these changes.
GLP-1 receptor agonists are increasingly used for weight loss, potentially benefiting patients needing joint replacement. However, concerns remain regarding surgical safety and long-term effects on bone and muscle health, necessitating further research and careful patient management.
The World Health Organization (WHO) has provided new guidance on using GLP-1 drugs like Ozempic and Wegovy for obesity. The recommendations include considerations for adults and highlight the importance of lifestyle changes alongside medication.
Aisling McCarthy, after years of struggling with her weight, has successfully lost 100lbs. Her transformation involved weight loss medication prescribed by her doctor, coupled with counseling, leading to a newfound sense of food freedom and improved well-being.
A clinical trial is underway to test a GLP-1 based weight loss treatment for overweight cats. The implant, releasing medication over six months, aims to improve insulin sensitivity and energy metabolism. Results are expected next summer.
